Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

Lemon Tree Hotels - Resilience amid turbulence - ICICI Securities

Posted On: 2020-10-30 08:22:32 (Time Zone: Arizona, USA)

We initiate coverage on Lemon Tree Hotels (LTH) with a BUY rating and SoTP-based target price of Rs37/share valuing its hotel business at 16x Sep'22E EV/EBITDA. We believe LTH is well poised to benefit from the expected recovery in the hotel business cycle from FY22E owing to its presence in the midscale and upper-midscale segments along with a higher share of domestic customers (85%). LTH's cost-saving initiatives post-Covid may drive a 500-700bps EBITDA margin improvement once demand normalises. Liquidity concerns have been addressed with APG, its PE partner, infusing Rs1.75bn in its subsidiary, Fleur, with an additional capital commitment of Rs1.25bn. Key risks are a prolonged Covid impact hitting occupancies in FY22E and structural slowdown in business travel.

- Branded mid-market hotel player across India: LTH is one of India's largest branded hotel chains, which operates in the mid-market sector, consisting of the upscale, upper-midscale, midscale and economy hotel segments. The company currently operates ~8,114 rooms in 81 hotels (including Keys Hotels) across 49 cities under its various brands, i.e. Aurika Hotels & Resorts, Lemon Tree Premier, Lemon Tree Hotels, Red Fox Hotels, Keys Prima, Keys Select, and Keys Lite. As the current pipeline becomes operational, LTH is expected to operate 108 hotels with ~10,700 rooms, across 68 cities in India and abroad.

- LTH's occupancy and ADRs expected to recover from FY22E: HVS Anarock expects a 19% YoY decline in CY20E industry Average Daily Rate (ADR) along with a 3,200bps drop in occupancy to 35% resulting in a 58% YoY fall in CY20E industry revenue per available room (RevPAR). Industry occupancies are expected to recover to 57.5% in CY21E and 65.5% in CY22E while industry ADRs may remain flat YoY in CY21E before recovering in CY22-23E. Similar to industry trends, we estimate that LTH will see a 48% YoY revenue decline in FY21E followed by a strong bounce-back in FY22E with revenues growing 73% YoY to Rs6.0bn and FY23E revenues of Rs7.5bn. Company has also implemented cost-saving initiatives from Q1FY21, which may enable it to achieve a 500-700bps EBITDA margin improvement once demand normalises. We model an EBITDA margin expansion of 675bps in FY22E to 42.4% compared to EBITDA margins of 30.7% in FY20 and 44.4% in FY23E.

- Valuations: Hotels are a deep cyclical business, which is usually hit the first during an economic downturn and is the last to recover in an upcycle. We expect a similar story to play out post-Covid with industry occupancies expected to reach pre-Covid levels only in FY23E. We value LTH at 16x Sep'22E EV/EBITDA, which is a 20% discount to long-term listed peer multiple of 20x. We initiate coverage with BUY and an SoTP-based target price of Rs37/share adjusted for APG share in Fleur Hotels.

Shares of Lemon Tree Hotels Ltd was last trading in BSE at Rs.27.1 as compared to the previous close of Rs. 27.3. The total number of shares traded during the day was 73950 in over 705 trades.

The stock hit an intraday high of Rs. 27.8 and intraday low of 26.65. The net turnover during the day was Rs. 2004991.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Maintain ADD on Symphony - Domestic in line; RoW improving - HDFC Securities

Maintain ADD on Multi Commodity Exchange - Taking a pause; recovery awaited - HDFC Securities

Maintain ADD on DCB Bank - Provisioning cushion emerges ahead of expectations - HDFC Securities

Maintain BUY on Birla Corporation - Margin buoyancy continues - HDFC Securities

ADD on SRF - Returning to normalcy - HDFC Securities

HDFC Securities - Maintain BUY on UltraTech Cement - Solid show!

Ajanta Pharma (Initiating Coverage) - Gearing for the next leap - HDFC Securities

BUY on SBI Life Insurance - Growth returns - HDFC Securities

Kajaria Ceramics (Initiating Coverage) - Galloping ahead - HDFC Securities

UltraTech Q3 FY21 - YES Securities

HDFC Life Q3 FY21 - YES Securities

SBI Life - Q3 FY21 - YES Securities

Aavas Financiers Q3 FY21 - Conference Call Takeaways - YES Securities

Birla Corp Q3 FY21 - YES Securities

ADD on Reliance Industries - Sailed through the tough times! - HDFC Securities

Grasim Industries - Aspiring for strong no.2 position in paints - ICICI Securities

Kewal Kiran Clothing - Better execution with flat EBITDA YoY - ICICI Securities

Mphasis - DXC will continue to be key in the near term - ICICI Securities

HDFC Securities: Indian Chemical Sector (Sector Update) - Steering well through the pandemic!

UltraTech Cement - Earnings upgrade continues; ripe for rerating - ICICI Securities

Multi Commodity Exchange of India - Lower turnover impacted operating performance - Q3FY21 - ICICI Securities

SBI Life Insurance Company - Strong performance, attractive valuations (<2 FY23 P/EV) - ICICI Securities

Biocon Limited - Slow recovery in biosimilars - ICICI Securities

HDFC Life Insurance Company - Not only - but also - about protection - ICICI Securities

DCB Bank - Gradually approaching normalcy - ICICI Securities

Aurobindo Pharma - Approval for 3 products under PLI Scheme - ICICI Securities

Yes Bank - Aggravating asset quality fears outweigh operating performance turnaround - ICICI Securities

JSW Steel - Peak margins expected in Q4FY21 - ICICI Securities

Aavas Financiers - Quality intact; premium to sustain - ICICI Securities

Supreme Industries - Q3FY21 First Cut - ICICI Direct

Polycab India Ltd - Q3FY21 First Cut - ICICI Direct

DCB Bank - Q3FY21 First Cut - ICICI Direct

Q3FY21 Result update - Symphony Ltd. - ICICI Direct

Ultratech Cement - Q3FY21 First Cut - ICICI Direct

Oberoi Realty - Q3FY21 First Cut - ICICI Direct

HDFC Life Insurance - Q3FY21 First Cut - ICICI Direct

SRF Limited - Chemical biz's good performance may continue - ICICI Securities

Multi Commodity Exchange of India - Lower turnover impacted operating performance - ICICI Securities

Q3FY21 Company update - Zensar Technologies - ICICI Direct

JSW Steel - Q3FY21 First Cut - ICICI Direct

Q3FY21 Result update - Biocon Ltd - ICICI Direct

Symphony Ltd - Q3FY21 First Cut - ICICI Direct

Crompton Greaves Consumer Electricals - Q3FY21 First Cut - ICICI Direct

Q3FY21 Result update - Bajaj Finserv - ICICI Direct

Q3FY21 Result update - Bajaj Auto - ICICI Direct

Quant Pick - Hero MotoCorp - ICICI Direct

Company update - Cyient Ltd - Q3FY21 - ICICI Direct

Covid Recovery Pulse - Auto retail taper off in new year 2021 - ICICI Direct

Q3FY21 Result update - Asian Paints - ICICI Direct

Company update - Mphasis Ltd - Q3FY21 - ICICI Direct

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020